The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
about
S-adenosyl-L-methionine for people with alcoholic liver diseaseGlucocorticosteroids for people with alcoholic hepatitisCurrent Management of Alcoholic Hepatitis and Future TherapiesManaging alcoholic liver diseaseUpdate on Alcoholic HepatitisLiver transplantation for alcoholic liver disease: Lessons learned and unresolved issuesDiagnosis and Management of Alcoholic Liver DiseaseAlcoholic liver disease: pathogenesis, management, and novel targets for therapyAlcoholic hepatitis: a comprehensive review of pathogenesis and treatmentAlcoholic liver disease: pathogenesis and new therapeutic targets.Alcoholic hepatitis and HCV interactions in the modulation of liver diseaseTherapy for alcoholic liver diseaseEmerging concepts in alcoholic hepatitisNon-invasive diagnosis of alcoholic liver disease.Diagnosis of alcoholic liver disease.Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.New therapeutic targets in alcoholic hepatitis.Focus on alcoholic liver disease: from nosography to treatment.Spontaneous evolution in bilirubin levels predicts liver-related mortality in patients with alcoholic hepatitis.Gaps in Knowledge and Research Priorities for Alcoholic Hepatitis.Bile acids trigger cholemic nephropathy in common bile-duct-ligated mice.Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis.Pharmacotherapy for alcoholic patients with alcoholic liver diseaseAlcoholic liver disease: treatmentAlcoholic hepatitis: current challenges and future directions.Severe alcoholic hepatitis-current concepts, diagnosis and treatment options.Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis.Treatment of alcoholic liver disease.Perceptions of post-transplant recidivism in liver transplantation for alcoholic liver disease.Treatment of decompensated alcoholic liver disease.Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.Cell death and cell death responses in liver disease: mechanisms and clinical relevanceSystemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis: A Sequential Analysis of Randomized Controlled Trials.Molecular targets in the treatment of alcoholic hepatitis.Management of alcoholic hepatitis: Current concepts.Liver Transplantation for Alcohol-Related Liver Disease
P2860
Q24188235-36BFEB1F-7CCF-4457-A6E8-43E4AC11DCF1Q26471655-FCB94EDE-E05D-43C3-AC02-A120542EB4E4Q26746544-45DA85CA-897F-495C-991C-06F6D8CA3023Q26777480-C9445C46-3FD9-46F8-9C7F-647047365CF0Q26779121-B6CED49C-B164-40F8-8578-4AFE817E973BQ26780281-582D4765-620A-49C4-9152-B52FF229EDB0Q26781876-F6DD8692-0C42-4A67-84B3-B8E1061EA719Q26861620-C9FE6C73-F29E-4E66-A4A6-C568B03DC8DFQ27027418-5602F184-C32B-44D3-B143-63A8B941FBF3Q27690220-C8EED03D-EA03-4148-B3BF-C8276E2F1C66Q28084063-972D22BD-AFED-466F-AFAE-4880BC0DA079Q28658193-E3915332-5B86-4836-8B60-AA7F2B23902CQ30234425-2F3831BA-AEB8-43E2-B497-D63615F787A3Q30427485-316169FB-F23D-4BF8-8FFB-B26655671648Q30431186-D098EAC7-67F3-4351-BEAD-B684737FBBA4Q33587538-EAA78668-17E0-427F-AE90-EAF4A8732679Q33595335-73181E46-5E94-4967-B968-F59DF2ACB83BQ33757267-9B6B09B3-C58C-4B0D-B69C-FC65335756E5Q33845458-BD10F68B-CC0E-426A-B00F-21C61E1DD865Q33889762-D05BDDDB-5A6F-444F-9958-95165870A457Q33903664-06ACC1F7-789E-4DE2-81CD-1F4469DBD790Q34037360-9C57D3A2-9634-44B0-A0F2-1441040224CCQ34060924-E5A15B0A-6C43-47C5-BE83-0502856A7A8FQ34223054-BD3CBCD6-46A1-48ED-AAA3-C6AF19FDDF5BQ34255479-9BF69FEF-9BE9-4F1F-A8C3-2EAE27807669Q34354286-E7D996F3-2659-47C7-9518-7867F1380BCDQ34404386-A0ABB46A-2C09-4F63-8C0B-9F1A0EF31272Q34450941-F7A20B55-3FCD-4825-BD49-68165FF432D7Q34565692-0125AC86-1738-4376-A7DE-B3AE26EC11A6Q34567968-96A872EA-E23D-467F-BB2C-8415590B5A1BQ35207505-853073A7-57AE-45E2-8059-D93DAE8B83D6Q35442766-A1CB36B1-78DF-44D6-B705-05A8FB7BFB6DQ35938040-EF3C69E2-9C67-40E5-AB0D-3BD14D15AA3FQ35995445-77861C05-6D0D-4DC0-A6B6-24D18FFA9235Q36021982-180B0FAD-B9E3-4FEA-AD31-DB18409FA9C0Q36038296-996D2E1D-B950-4DB1-8F7F-DFCF5C936A0EQ36073872-07776938-8376-4E3F-BE51-4B5BD29432D5Q36351877-560EC622-07DC-4EB6-AD59-78CD2E78CD11Q36561560-98F662A5-F611-4C3B-A208-61EB8963370FQ36886533-55E3547C-9357-462D-8CD7-C6F6F6142998
P2860
The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The Lille model: a new tool fo ...... patitis treated with steroids.
@ast
The Lille model: a new tool fo ...... patitis treated with steroids.
@en
The Lille model: a new tool fo ...... patitis treated with steroids.
@nl
type
label
The Lille model: a new tool fo ...... patitis treated with steroids.
@ast
The Lille model: a new tool fo ...... patitis treated with steroids.
@en
The Lille model: a new tool fo ...... patitis treated with steroids.
@nl
prefLabel
The Lille model: a new tool fo ...... patitis treated with steroids.
@ast
The Lille model: a new tool fo ...... patitis treated with steroids.
@en
The Lille model: a new tool fo ...... patitis treated with steroids.
@nl
P2093
P50
P356
P1433
P1476
The Lille model: a new tool fo ...... epatitis treated with steroids
@en
P2093
Emmanuel Diaz
François-René Pruvot
Frédéric Texier
Laetitia Fartoux
Lawrence Serfaty
Marcelle Abdelnour
Marie-José Ramond
Pierre Deltenre
Sylvie Naveau
Sébastien Dharancy
P2860
P304
P356
10.1002/HEP.21607
P407
P577
2007-06-01T00:00:00Z